The possibility of Bartonella clarridgeiae being a causative agent of cat scratch disease (CSD) was investigated by using indirect fluorescence antibody assays with 288 suspected CSD patients. Immunoglobulin G antibody to noncocultivated B. clarridgeiae was suitable only for detection of B. clarridgeiae antibody. Significant cross-reactivity between Bartonella henselae and B. clarridgeiae was noted, and no CSD case caused by B. clarridgeiae was detected.
The predominant causative pathogen for cat scratch disease (CSD) is Bartonella henselae (1, 2, 6) . Since the isolation of Bartonella species from CSD patients is difficult, indirect fluorescence antibody assay (IFA) for detection of antibodies to Bartonella species is commonly used for serological diagnosis and epidemiological studies (5, 14, 19, 23) .
Recently, B. clarridgeiae was suggested as an additional causative agent of CSD (9, 11) . This prompted us to reanalyze sera of patients clinically suspected of having CSD, and we investigated the prevalence of immunoglobulin G (IgG) and IgM antibodies to B. clarridgeiae among such patients in Japan.
For detection of IgG and IgM antibodies to B. clarridgeiae, two IFA protocols were evaluated. To investigate cross-reactivity between B. henselae and B. clarridgeiae, 1 ml of each sample from 20 patients with serum titers of IgG antibody to B. clarridgeiae of Ն1:128 was absorbed with 2 mg of B. henselae ATCC 49882 or B. clarridgeiae ATCC 51734 and then tested by IFA. For scanning electron microscopy, B. clarridgeiae cocultivated with Vero cells on small pieces of cover glass was incubated with a 1/50 dilution of the tested sera for 90 min at 35°C in 5% CO 2 , followed by the protein A-gold labeling (21) , and processed and examined as described previously (20) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis were performed as described previously (10, 22) .
Comparison of two IFA protocols. (i) IgG and IgM antibodies to cocultivated B. clarridgeiae. IgG antibody to B. clarridgeiae was analyzed by IFA using B. clarridgeiae cocultivated with Vero cells for 24 and 96 h at 35°C in 5% CO 2 , as described previously (19) . B. clarridgeiae cocultivated with Vero cells for 24 h strongly reacted with 20 healthy human sera (1:2,048 to 1:4,056) (Fig. 1A) . When B. clarridgeiae was cocultivated for 96 h, the titers increased by about eight times (1:16, determinants in B. clarridgeiae. Scanning electron microscopy also showed its nonspecific reaction (Fig. 2) . Numerous gold particles were labeled on the surface of B. clarridgeiae cocultivated with Vero cells for 72 h, whereas a few gold particles were observed after 3 h of cocultivation. IgM antibody to B. clarridgeiae was not measured because many nonspecific fluorescences were observed around Vero cells in all samples. Altogether, IgG antibody to noncocultivated B. clarridgeiae was suitable only for detection of B. clarridgeiae antibody.
The association of B. clarridgeiae with CSD. Of the total of 100 sera from healthy individuals with no past history of either lymph node swelling or cat scratch or bite, 3 (3.2%) of 94 sera serologically negative for IgG antibody to B. henselae and 3 (50.0%) of 6 sera with titers of IgG antibody to B. henselae of 1:64 to 1:128 were positive for IgG antibody to B. clarridgeiae, with titers of 1:64 to 1:128 (Table 1) .
Sera from 288 patients (221 children and 67 adults) clinically suspected of having CSD because of either lymphadenopathy or fever of unknown origin and a previous history of cat scratch or contact were reevaluated for IgG antibody to B. clarridgeiae. Paired acute-phase and convalescent-phase sera were obtained from 35 patients. They were divided into three groups by titers of IgG antibody to B. henselae. Group 1 included 145 samples with titers of Ͻ1:64, group 2 included 59 patients whose sera had titers of 1:64 to 1:128, and group 3 included 84 samples with titers of Ն1:256. In group 1, 4 (2.8%) were positive for B. clarridgeiae with a titer of 1:64, and 14 (23.7%) of group 2 and 45 (53.6%) of group 3 were positive for IgG antibody to B. clarridgeiae with titers of 1:64 or more (Table 1) . One patient's serum had high titers of 1:1,024 for IgG antibody to B. clarridgeiae and 1:4,096 for IgG antibody to B. henselae. Thus, the positive rate for B. clarridgeiae IgG increased significantly in proportion to the increase of the titer of B. henselae IgG among suspected CSD patients (P Ͻ 0.0001 for group 1 versus group 2; P ϭ 0.02 for group 2 versus group 3). None of paired sera from 35 patients showed a fourfold rise in titers of IgG antibody to B. clarridgeiae. There was no difference in the positive rate for IgG for B. clarridgeiae between the control group and group 1 (P ϭ 1.000).
Serological cross-reaction. When the sera were absorbed with B. henselae, titers of IgG for both B. henselae and B. clarridgeiae were significantly reduced or disappeared (Table  2) . When the sera were absorbed with B. clarridgeiae, titers of IgG antibody to B. henselae did not change, whereas titers of IgG antibody to B. clarridgeiae were not detected. Western blotting with a CSD patient's serum showed that it reacted predominantly with a 58-kDa protein of B. henselae and 58-, 37-, and 32-kDa proteins of B. clarridgeiae (Fig. 3B) . The serum absorbed with B. henselae resulted in diminished reaction, and there was no band reacting with either strain (Fig. 3C) . On the contrary, the serum absorbed with B. clarridgeiae still reacted against a 73-kDa protein of B. henselae (Fig. 3D ). Although this protein band was thin, its intensity was the same as that of unabsorbed serum ( Fig. 3B and D) . In view of the facts that cats are infected with both B. henselae and B. clarridgeiae simultaneously (4, 8, 12) , B. clarridgeiae could be a causative agent of CSD (9, 11) , and there was cross-reaction between B. henselae and B. clarridgeiae, as 
